期刊文献+

辛伐他汀对冠心病患者血液流变学的影响

Effect of simvastatin on blood rheology in patients with coronary heart disease
下载PDF
导出
摘要 目的 研究辛伐他汀对冠心病患者血液流变学的影响。方法 观察 61例冠心病患者辛伐他汀治疗前后血脂及血液流变学变化。结果 冠心病患者服用辛伐他汀血脂下降、血液流变学指标有明显改善 ,治疗前后比较有显著性差异 ( P <0 .0 1 )。结论 辛伐他汀能降低冠心病血脂水平 。 Objective To investigate the changes of blood rheology after using simvastatin with coronary heart disease.Methods The changes of blood lipid and blood rheology before and after the treatment with simvastatin were observed and analysed in 61 cases of coronary heart disease.Results The significant effects and differences of blood lipid and blood rheology were observed before and after the treatment with simvastatin (P<0 01).Conclusions Simvastatin can effectively lower the level of blood lipid of the coronary diseas and at the sime time it can also improve the status of the blood rheology.
出处 《医学文选》 2004年第3期275-276,共2页 Anthology of Medicine
关键词 辛伐他汀 冠心病 血液流变性 Simvastatin Coronary heart disease Hemo-rheology
  • 相关文献

参考文献7

  • 1张旭明,伍卫.辛伐他汀的临床应用与展望[J].中国药学杂志,2000,35(1):5-8. 被引量:34
  • 2高凤英,刘承巨,李松梅.49例冠心病患者甲襞微循环的临床观察分析[J].中国血液流变学杂志,1998,8(2):26-27. 被引量:7
  • 3郭谕成.冠心病患者微循环中微血栓形成的血液流变性变化[J].中国血液流变学杂志,1995,51(1):14.
  • 4[4]MASS Investitors. Effect of simvastatin on coronary atheroma. The Multicenter Anti-Aherochke Study (MASS) [J].Lancet , 1994,344: 633~ 638
  • 5[5]Waters D, Higginson L, Gladstone P, et al. Effects of monotherapy with an HMG GoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography: the canadia coronary atherosclerosis intervention trial [J]. Ccirculation, 1994,89:959~968
  • 6[6]Kaesemeyer WH,Caldwell RB,Huang JZ,et al. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering action[J]. J Am Coll cardiol, 1999,33: 234~241
  • 7王立赞,朱凡河,林琳.L-精氨酸对家兔内源性一氧化氮释放和血液流变性的影响[J].微循环学杂志,2000,10(1):23-25. 被引量:7

二级参考文献7

  • 1中华心血管病杂志编辑委员会血脂异常防治对,中华心血管病杂志,1997年,25卷,169页
  • 2Yaughan C J,Lancet,1996年,348卷,1079页
  • 31,Mccall T, Vallance P. Nitric oxidetakes centerstage with newly define d roles. TIPS, 1992, 13:1.
  • 42,Palmer RM. Ferrige AG, Moncada S. Nitric oxide release accounts for th e biologicalactivity of endothelium-derived relaxing factor. Nature, 1987, 327 :524.
  • 53,Faraci FM. Role of nitric oxide in regulation of basilar artery tone i n vivo. Am JPhysiol, 1990, 259:1 216.
  • 64,Moncada S, Palmer RM, Higgs EM. Nitric oxide: Physiology, Pethophysiol ogy,Pharmacology. Pharmacol Rev, 1991, 43:109.
  • 75,JacksonWF.Theendothelium-derivedrelaxingfactor.JReconstrMicrosurg,1989,5:263. 本文1999-03-29收到,1999-12-27接受

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部